Prot #19769: An Open-label, Multi-center, Phase 1b/2 Study To Evaluate The Safety And Efficacy Of Copanlisib In Combination With Nivolumab In Patients With Advanced Solid Tumors

Project: Research project

Project Details

StatusFinished
Effective start/end date2/16/21 → 2/16/24

Funding

  • Covance Inc. (Prot #19769 // Prot #19769)
  • Bayer HealthCare Pharmaceuticals, Inc. (Prot #19769 // Prot #19769)